Sign in to view content

Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

Geoff G. Emerson, MD, PhD, FASRS

Video
Published 2021

Related

Predictors of Post-injection Endophthalmitis: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength
Tarek S. Hassan, MD, FASRS
Updates from the Field
2019
Cooling Anesthesia for Intravitreal Injection With a Novel Device: Results of the Prospective COOL-2 Study
Daniel L Chao, MD, PhD
Annual Meeting Talks
2020
Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Updates from the Field
2019

Category: Socioeconomics

See more